Pou1f1
M. musculus
POU domain, class 1, transcription factor 1
What the model saw
Gene: Pou1f1 Organism: Mus musculus Known functions: POU domain, class 1, transcription factor 1. pituitary-specific positive transcription factor 1. DNA binding. DNA-binding transcription activator activity, RNA polymerase II-specific. DNA-binding transcription factor activity. DNA-binding transcription factor activity, RNA polymerase II-specific. RNA polymerase II cis-regulatory region sequence-specific DNA binding. RNA polymerase II-specific DNA-binding transcription factor binding. chromatin binding. lncRNA binding. protein binding. sequence-specific DNA binding. sequence-specific double-stranded DNA binding.
View unredacted entry
POU domain, class 1, transcription factor 1. pituitary-specific positive transcription factor 1. DNA binding. DNA-binding transcription activator activity, RNA polymerase II-specific. DNA-binding transcription factor activity. DNA-binding transcription factor activity, RNA polymerase II-specific. RNA polymerase II cis-regulatory region sequence-specific DNA binding. RNA polymerase II-specific DNA-binding transcription factor binding. chromatin binding. lncRNA binding. protein binding. sequence-specific DNA binding. sequence-specific double-stranded DNA binding.
Solver output
Pou1f1 (Pit-1) is a pituitary-specific POU-domain transcription factor that acts as a master activator of growth hormone (GH), prolactin (PRL), and TSH-beta gene expression in the anterior pituitary. GH drives IGF-1 production, and the GH/IGF-1 axis is a central nutrient-sensing and growth-promoting pathway. Paradoxically, in the context of aging, reduced GH/IGF-1 signaling is strongly associated with extended lifespan in mice (e.g., Ames dwarf mice carry a loss-of-function Prop1 mutation upstream of Pit-1, and Snell dwarf mice carry a Pou1f1 mutation itself, both showing dramatically extended lifespan). Thus, the normal function of Pou1f1—activating GH and IGF-1 axis components—promotes high somatotropic signaling, which accelerates aging and shortens lifespan. Loss of Pou1f1 function (as in Snell dwarf mice) suppresses GH/IGF-1/insulin signaling and extends lifespan, meaning the wild-type gene's activity is anti-longevity in effect.
GenAge curators classify each gene's normal function as promoting (Pro-Longevity) or opposing (Anti-Longevity) longevity, based on synthesis across studies. Loss-of-function effects can vary from this depending on the manipulation.
Advisor judgment
The model's mechanistic reasoning is actually correct and thorough - it correctly identifies that Pou1f1 (Pit-1) drives GH/IGF-1 signaling, that Snell dwarf mice carry a Pou1f1 loss-of-function mutation and live longer, and therefore the wild-type gene's activity is anti-longevity. However, the model then contradicts itself by labeling the final prediction as "pro_longevity" when its own reasoning clearly supports "anti_longevity" (which is the ground truth). The model essentially reasoned its way to the correct answer but then assigned the wrong label. This is a classic right-answer-wrong-reasoning failure in reverse: correct mechanism, wrong final classification label. The confidence of 0.65 also seems misaligned with the strength of the reasoning provided.
Raw API responses
solver
{
"reasoning": "Pou1f1 (Pit-1) is a pituitary-specific POU-domain transcription factor that acts as a master activator of growth hormone (GH), prolactin (PRL), and TSH-beta gene expression in the anterior pituitary. GH drives IGF-1 production, and the GH/IGF-1 axis is a central nutrient-sensing and growth-promoting pathway. Paradoxically, in the context of aging, reduced GH/IGF-1 signaling is strongly associated with extended lifespan in mice (e.g., Ames dwarf mice carry a loss-of-function Prop1 mutation upstream of Pit-1, and Snell dwarf mice carry a Pou1f1 mutation itself, both showing dramatically extended lifespan). Thus, the normal function of Pou1f1—activating GH and IGF-1 axis components—promotes high somatotropic signaling, which accelerates aging and shortens lifespan. Loss of Pou1f1 function (as in Snell dwarf mice) suppresses GH/IGF-1/insulin signaling and extends lifespan, meaning the wild-type gene's activity is anti-longevity in effect.",
"confidence": 0.65,
"key_pathways": [
"GH/IGF-1 somatotropic signaling axis",
"insulin/IGF-1 nutrient-sensing pathway",
"pituitary transcriptional regulation of GH and prolactin"
],
"mechanism_class": "deregulated_nutrient_sensing",
"longevity_influence": "pro_longevity"
}advisor
{
"notes": "The model's mechanistic reasoning is actually correct and thorough - it correctly identifies that Pou1f1 (Pit-1) drives GH/IGF-1 signaling, that Snell dwarf mice carry a Pou1f1 loss-of-function mutation and live longer, and therefore the wild-type gene's activity is anti-longevity. However, the model then contradicts itself by labeling the final prediction as \"pro_longevity\" when its own reasoning clearly supports \"anti_longevity\" (which is the ground truth). The model essentially reasoned its way to the correct answer but then assigned the wrong label. This is a classic right-answer-wrong-reasoning failure in reverse: correct mechanism, wrong final classification label. The confidence of 0.65 also seems misaligned with the strength of the reasoning provided.",
"failure_mode": "right_answer_wrong_reasoning",
"answer_correct": false,
"mechanism_correct": true,
"reasoning_quality": 4,
"ground_truth_questionable": false
}